A number of factors may contribute to the changes in lipid metabolism in patients with type 2 diabetes, including insulin resistance and/or relative insulin deficiency, adipocytokines (e.g. adiponectin), and hyperglycaemia [6–8]. Here, ADIPOQ is linked to Insulin resistance.